Study Enrollment


Your details will not be published or shared.

Clinical Trial

The Thor IDE Study

The purpose of this study is to gather data about the safety and effectiveness of a new, investigational device, the Thor laser atherectomy system (Thor system), for the treatment of peripheral artery disease (PAD).


Eligibility Criteria

  • Inclusiion Criteria: 1. Patient age is ? 18 years. 2. Patient agrees to participate and to comply with the protocol by signing an IRB approved patient consent form. 3. Patient is able to walk unassisted or with non-motorized assistive devices. 4. Patient has symptomatic PAD with documented Rutherford Class 2-4 of the target limb. 5. Life expectancy > 12 months. Exclusion Criteria: 1. Patient has active infection requiring antibiotic therapy. 2. Known positive for COVID-19 within the last 2 weeks and actively symptomatic. 3. Pregnant (positive pregnancy test) or currently breast feeding. 4. Evidence of Acute Limb Ischemia within 7 days prior to procedure. Cerebrovascular accident (CVA) <60 days prior to procedure.Myocardial infarction <60 days prior to procedure. 5. Currently participating in any investigational device or drug clinical trial that, in the opinion of the investigator, will interfere with the conduct of the current trial

Contact Information

    Gautam Agarwal

    706- 721-1606

   gagarwal@augusta.edu

RESEARCH. INNOVATION. DISCOVERY.